Latest News about GLPG
Recent news which mentions GLPG
A Short Delay Is Still Bad News for AbbVie
April 13, 2021
From Motley Fool
The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs
March 26, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 24, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 23, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 17, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 26, 2021
From Benzinga
Is Galapagos Stock a Bad-News Buy Right Now?
February 23, 2021
From Motley Fool
Galapagos NV (GLPG) Q4 2020 Earnings Call Transcript
February 19, 2021
Tickers
GLPG
From Motley Fool
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
February 17, 2021
From Benzinga
10 Health Care Stocks With Unusual Options Alerts In Today's Session
February 16, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 12, 2021
From Benzinga
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
February 12, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 11, 2021
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
94 Biggest Movers From Yesterday
February 11, 2021
From Benzinga
Gilead Sciences and Galapagos Shutter Their Pulmonary Fibrosis Program
February 10, 2021
From Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 10, 2021
From Benzinga
Galapagos, Gilead Sciences Pull Plug On Ziritaxestat Clinical Trials
February 10, 2021
From Benzinga
The Gilead, Galapagos Pipeline Opportunities That Are Turning Morgan Stanley Bullish
January 19, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2021
January 19, 2021
From Benzinga
The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data
December 18, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 17, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.